世界中医药
文章摘要
引用本文:范才文,贺小英,罗树云.血脂康胶囊治疗脂肪肝的疗效观察[J].世界中医药,2012,7(4):.  
血脂康胶囊治疗脂肪肝的疗效观察
Efficacy Observation on Xuezhikang Capsule in Treating Fatty Liver
投稿时间:2012-05-02  
DOI:
中文关键词:  血脂康  脂肪肝  疗效观察
English Keywords:Xuezhikang  Fatty liver  Efficacy Observation
基金项目:
作者单位
范才文,贺小英,罗树云 北京市朝阳区第二医院内科100026 
摘要点击次数: 1089
全文下载次数: 1552
中文摘要:
      目的:观察血脂康胶囊对脂肪肝的疗效及安全性。方法:将入选的198例脂肪肝患者随机分为治疗组(99例)和对照组(99例),治疗组在控制饮食和适当活动的基础上加用血脂康胶囊2粒(0.3g/粒)po.bid,对照组采取控制饮食和适当活动,共观察12周。结果:治疗组脂肪肝的显效率为47%,有效率为45%,总有效率为92%。同比对照组显效率20%,有效率24%,总有效率44%,差异有统计学意义(P<0.01)。结论:血脂康胶囊治疗脂肪肝疗效显著且较安全,并能显著降低血脂,改善肝功能,从而防止肝纤维化和肝硬化,价格低廉,值得临床推广使用。
English Summary:
      To evaluate efficacy and safety of Xuezhikang Capsule in Treating fatty liver. Methods: A total of 198 patients were randomly divided into 2 groups. The treatment group (n=99) received Xuezhikang Capsules po bid in addition to diet and exercise control, and control group (n=99) only received diet and exercise control, for a course of 12 weeks. Results: Of the treatment group, the response rate was 47%, effective rate was 45%, total effective rate was 92%, compared with respectively 20%, 24%, 44% of the control group (P<0.01). Conclusion: Xuezhikang Capsules is effective and safe to treat fatty liver, significantly lowers blood lipids and improves liver function, so as to prevent Liver fibrosis and hepatic cirrhosis. With competitive cost, Xuezhikang Capsules is suitable for clinical application.
查看全文  查看/发表评论  下载PDF阅读器